Frank Rimerman Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Sell |
3,246
-304
| -9% | -$135K | 0.1% | 155 |
|
|
2025
Q1 | $1.72M | Buy |
3,550
+278
| +8% | +$135K | 0.14% | 119 |
|
|
2024
Q4 | $1.32M | Sell |
3,272
-2,036
| -38% | -$820K | 0.1% | 151 |
|
|
2024
Q3 | $2.47M | Sell |
5,308
-1
| -0% | -$465 | 0.18% | 101 |
|
|
2024
Q2 | $2.49M | Buy |
5,309
+5,297
| +44,142% | +$2.48M | 0.18% | 96 |
|
|
2024
Q1 | $5.02K | Hold |
12
| – | – | ﹤0.01% | 208 |
|
|
2023
Q4 | $4.88K | Buy |
+12
| New | +$4.88K | ﹤0.01% | 201 |
|